Results 101 to 110 of about 7,908 (187)

Letter Re: Quality-adjusted survival in patients with metastatic colorectal cancer treated with fruquintinib plus best supportive care: results from FRESCO-2. [PDF]

ESMO Open
Zhu W, Wei Z, Xie R.
europepmc   +1 more source

Third-line treatment decision-making for metastatic colorectal cancer: a cross-sectional survey of US community physicians. [PDF]

Oncologist
Cann C, Zhao S, Khan N, O'Donnell M, Taylor M, Salimi T.   +5 more
europepmc   +1 more source

Correction to: A Canadian real‑world, multi‑center, prospective, observational study assessing the treatment duration, the treatment sequence, and the overall survival for patients treated with endocrine therapy ± targeted therapy in HR + HER2‑negative advanced breast cancer. [PDF]

Breast Cancer Res Treat
Doyle C, Lohmann AE, Iqbal N, Henning JW, Kulkarni S, Califaretti N, Hilton J, Ferrario C, Bouganim N, Mates M, Guillemette S, Leite R, Caron MA, Thireau F, Machado A, Chia S.   +15 more
europepmc   +1 more source

Small family cheesemaking in Mexico: Microbial quality and good manufacturing practices. [PDF]

JDS Commun
Ibarra-Sánchez LA, Olvera-Aguilar AL, Caltzontzin-Fernández KK, Cabrera-Luna JA.   +3 more
europepmc   +1 more source

Proceedings of the world summit on parkinson's disease. [PDF]

NPJ Parkinsons Dis
Mantri S, Ghilardi MF, Lessard N, Norcini M, Di Rocco A, Wallock K, Lehr J, Okun MS, World Summit Steering Committee.   +8 more
europepmc   +1 more source

Colchicine Suppresses Adipogenic Differentiation of Mesenchymal Stem Cells: Implications for Bone Adiposity Control. [PDF]

Pharmaceutics
López-Fagúndez M, Piñeiro-Ramil M, Pazos-Pérez A, Guillán-Fresco M, López V, Ait Eldjoudi D, Bravo-López SB, Jorge-Mora A, Alonso-Pérez A, Gómez R.   +9 more
europepmc   +1 more source

Safe Administration of Fruquintinib in a Hemodialysis Patient with Metastatic Colorectal Cancer: A Case Report. [PDF]

Case Rep Oncol
Takemura K, Murakawa Y, Kono H, Suemasu M, Kuroda A, Yamaguchi T, Tanabe Y, Suyama K, Uchino K.   +8 more
europepmc   +1 more source

Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer: safety analysis of FRESCO-2. [PDF]

Oncologist
Eng C, Dasari A, Lonardi S, Garcia-Carbonero R, Elez E, Yoshino T, Sobrero A, Yao J, Garcia-Alfonso P, Kocsis J, Gracian AC, Sartore-Bianchi A, Satoh T, Randrian V, Tomasek J, Chong G, Yang Z, Guevara F, Schelman W, Pallai R, Tabernero J.   +20 more
europepmc   +1 more source